STOCK TITAN

Vanguard disaggregates holdings; Electromed (ELMD) shows 0 shares reported

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Electromed Inc: The Vanguard Group filed an Amendment No. 1 to Schedule 13G reporting beneficial ownership of 0 shares (0%) of Common Stock. The filing states Vanguard completed an internal realignment on January 12, 2026 and will report certain subsidiaries separately "in accordance with SEC Release No. 34-39538 (January 12, 1998)".

The amendment lists Vanguard's address and shows no sole or shared voting or dispositive power over Electromed shares. The signature block is by Ashley Grim, Head of Global Fund Administration, dated 03/26/2026.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports zero beneficial ownership after internal disaggregation.

The filing states 0 shares (0%) beneficially owned and zero voting and dispositive powers, reflecting a reallocation of holdings among Vanguard entities following an internal realignment on January 12, 2026. The amendment cites SEC Release No. 34-39538 (January 12, 1998) as the basis for separate reporting.

Cash-flow treatment and any underlying account-level holdings are not disclosed in the excerpt; subsequent 13G/A filings from Vanguard affiliates may show redistributed positions.

Administrative reporting change, not a change in company control.

The amendment documents an administrative disaggregation rather than an acquisition or disposition: it explains that subsidiaries will report separately and that Vanguard "no longer has, or is deemed to have, beneficial ownership" of securities held by those subsidiaries per the cited SEC release.

Monitor future filings for reaggregated holdings or per-affiliate 13G/A entries if assessing investor concentration.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does Electromed (ELMD) Schedule 13G/A amendment state about Vanguard's holdings?

It states The Vanguard Group beneficially owns 0 shares (0%) of Electromed Common Stock, with no sole or shared voting or dispositive power, according to the amendment.

Why did Vanguard file this Schedule 13G/A amendment for ELMD?

Vanguard reports an internal realignment completed on January 12, 2026, and per SEC Release No. 34-39538 it is disaggregating certain subsidiaries to report ownership separately.

Who signed the Electromed 13G/A amendment for Vanguard (ELMD)?

The amendment is signed by Ashley Grim, Head of Global Fund Administration, with the signature date shown as 03/26/2026.

Does the filing show Vanguard retains voting or dispositive power over ELMD shares?

No. The filing lists 0 shares for sole voting power, shared voting power, sole dispositive power, and shared dispositive power in each corresponding item.

Will this amendment change Electromed's shareholder register or control?

This amendment documents reporting changes by Vanguard affiliates and shows 0% ownership; it does not state any transfer of control or company-level change.
Electromed

NYSE:ELMD

View ELMD Stock Overview

ELMD Rankings

ELMD Latest News

ELMD Latest SEC Filings

ELMD Stock Data

202.33M
6.50M
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
NEW PRAGUE